The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Biogen Idec's 2013 Oncology and CNS sales performance.
While there are currently no licensed DMDTs in the UK, several are at varying stages of development and regulatory approval, including Eisai and Biogen’s lecanemab and Eli Lilly’s donanemab.
better.”. Last month, new data showed that a weekly subcutaneous dose of Biogen and Eisai’s Alzheimer’s disease drug Leqembi (lecanemab-irmb) removed 14% more amyloid plaque than the
Biogen and Eisai’s Alzheimer’s disease drug has shown promise as a subcutaneous (SC) formulation, according to new data presented by Eisai at this year’s Clinical Trials on
Biogen and Bio-Thera signed a global commercialisation agreement for Tofidence in 2021. ... In a statement, Biogen said it is “currently evaluating the potential launch timeline for Tofidence in the US”.
Participants will also have the opportunity to take part in new research studies as well as potentially take part in the testing of new therapies, including Biogen’s Qalsody (tofersen), the
No results were found
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...